Dr. Chay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
551 Brevard Rd
Asheville, NC 28806Phone+1 828-212-7021Fax+1 828-232-8218
Education & Training
- University of MichiganFellowship, Hematology and Medical Oncology, 1999 - 2002
- University of North Carolina HospitalsResidency, Internal Medicine, 1996 - 1999
- University of North Carolina at Chapel Hill School of MedicineClass of 1996
Certifications & Licensure
- NC State Medical License 1996 - 2025
- MI State Medical License 1998 - 2003
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2010 Mar 31
- S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride Start of enrollment: 2011 Nov 15
- S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy Start of enrollment: 2013 May 15
- Join now to see all
Publications & Presentations
PubMed
- 34 citationsAdjuvant and neoadjuvant therapy in prostate cancerChristopher H. Chay, David Smith
Seminars in Oncology. 2001-02-01 - 6 citationsBRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naive mantle cell lymphoma.Toby A Eyre, Nirav N Shah, Martin Dreyling, Wojciech Jurczak, Yucai Wang
Future Oncology. 2022-11-01 - 79 citationsA functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines.Christopher H. Chay, Carlton R. Cooper, James D. Gendernalik, Saravana M. Dhanasekaran, Arul M. Chinnaiyan
Urology. 2002-11-01
Press Mentions
- Cancer Clinical Trials As-Care-Option Moves into Western North Carolina via Messino Cancer Centers & Sarah Cannon Research Institute PartnershipNovember 17th, 2020
- Messino Cancer Centers Opens in Western North Carolina and Joins the American Oncology Network, LLCJanuary 7th, 2020
- American Oncology Network : Messino Cancer Centers Strengthens Commitment to Patient Care with New PhysicianJune 4th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: